Abivax (ABVX) Receivables - Other: 2023-2025
- Abivax's Receivables - Other fell 12.26% to $19.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $19.4 million, marking a year-over-year decrease of 12.26%. This contributed to the annual value of $20.2 million for FY2024, which is 24.46% down from last year.
- As of Q2 2025, Abivax's Receivables - Other stood at $19.4 million, which was down 14.47% from $22.7 million recorded in Q1 2025.
- In the past 5 years, Abivax's Receivables - Other registered a high of $26.7 million during Q4 2023, and its lowest value of $19.4 million during Q2 2025.
- Its 3-year average for Receivables - Other is $22.2 million, with a median of $22.1 million in 2024.
- Data for Abivax's Receivables - Other shows a maximum YoY fell of 24.46% (in 2024) over the last 5 years.
- Abivax's Receivables - Other (Quarterly) stood at $26.7 million in 2023, then decreased by 24.46% to $20.2 million in 2024, then dropped by 12.26% to $19.4 million in 2025.
- Its Receivables - Other was $19.4 million in Q2 2025, compared to $22.7 million in Q1 2025 and $20.2 million in Q4 2024.
